Potential limitations include: Limited long-term human data Variable patient response Cost considerations Need for ongoing monitoring Off-label prescribing considerations These therapies are generally avoided in patients with: Active malignancy Pregnancy or breastfeeding Significant uncontrolled endocrine disease Certain metabolic conditions Monitoring and Safety Where prescribed, monitoring may include: IGF-1 levels Functional recovery Sleep quality Rehabilitation tolerance Adverse effects Overall clinical progress Treatment should always be part of a broader recovery plan rather than a standalone intervention
Work with a licensed clinician who understands fertility and peptides
We are constantly working to expand our catalog, introduce new and innovative products, and enhance the overall experience for our customers
The science behind peptide therapy is still emerging, and some applications are currently based on early-stage clinical research
Redox Signal 24 , 680712 (2015)
[55, 56, 57] Interestingly, reducing iodine intake with a low-iodine diet has been shown to normalize serum thyroid markers and symptoms for some
